Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

NCT01347801 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypoglycaemia

Interventions

DRUG: GLP-1
DRUG: Placebo (Saline)
DRUG: TNF-alfa
OTHER: OGTT
OTHER: IVGTT

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]
[object Object]